Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
American Express heads into its October 23 earnings report with the Street's price targets falling faster than the stock itself, a gap that frames everything worth watching on this name right now.
The analyst pressure has intensified since the last note. UBS cut its target to $345 from $384 on October 5, a drop of nearly $40 in a single move, while keeping a Neutral rating. Barclays trimmed to $342 from $364 the same day. TD Cowen followed on October 6 with a modest cut to $335, also Hold. These join reductions from Evercore ISI (to $320 from $370) and Citigroup (to $340 from $355, flagged in the prior note) over the same two-week stretch. The direction is one-way: even analysts who remain constructive are pulling targets lower. The mean consensus target now stands near $371, implying about 22% upside against a price of $304.55. That gap looks generous on paper, but it has compressed from both ends as targets drift down and the stock sits near its monthly lows, off 6.6% over the past month. Truist's Brian Foran retains the most prominent bull case among those who have moved recently, holding a Buy with a $370 target after trimming it from $375 in late September. Piper Sandler's Overweight with a $405 target, last updated in August, is the highest on the Street, though that note is now nearly two months old.
The bear case in focus centres on new card acquisition, which fell both quarter-over-quarter and year-over-year in the most recent print. Bears argue the company needs to cut marketing spend meaningfully just to hit its 2026 EPS targets, and that the Platinum Card refresh masked an underlying stall in revenue growth. The bull rebuttal points to new account growth in Consumer and Commercial segments as a partial offset to spending deceleration, and to card fee expansion as a sign that demand for the product itself remains intact. The analyst recommendation divergence factor scores in the 99th percentile, meaning the spread of views is wider than almost any other name in the universe, a reflection of genuine disagreement rather than a tidy consensus. The PE multiple has contracted about 1.3 points over the past 30 days to around 15.6x, while the price-to-book has eased to roughly 5.4x, both moving in the direction that value-oriented bulls have been waiting for.
Short positioning is not a meaningful part of this story. Short interest runs at just 1.55% of the free float, barely changed over the week, and borrow availability is essentially unlimited, with no constraint on the lending side at all. Cost to borrow has ticked up over the past month but remains under 0.40%, well within normal range for a large-cap financial. Options positioning is mildly constructive: the put/call ratio at 0.64 is slightly below its 20-day average of 0.65 and well below the 52-week high of 0.84, suggesting options traders are not aggressively hedging into the print. The ORTEX short score of 33.4 has been essentially flat for two weeks, reflecting a stock where the short-selling community has little conviction in either direction.
Berkshire Hathaway's 22.5% stake remains the defining ownership fact. That holding has not moved in the most recent reporting period, and its presence sets a practical floor on how far institutional sentiment can deteriorate. BlackRock and State Street both added modestly in the most recent quarter. The FDIC call report data flagged by ORTEX Alt Data shows record Q2 net income and total assets for the company's insured bank operations, though neither dataset has yet accumulated enough history for a tested lead relationship against the quarterly print. The consumer credit trust data shows AXP's net charge-off rate ranking in the bottom decile against peer trusts as of mid-September, a notable credit quality signal, and delinquencies are also running below the peer median. These are not forecasts for the October print, but they are the credit quality indicators the bears will be watching most closely when the results land.
The October 23 report arrives with the stock having delivered mild negative reactions to each of the last two prints, a 1.6% drop after July's Q2 release and a 0.8% gain after May's Q1. What changes this cycle is the volume of target cuts immediately preceding the announcement: the question on October 23 is whether the Street has already reset expectations low enough that the acquisition and spending data arrives in line with a revised bar, or whether the deceleration runs deeper than even the freshly trimmed forecasts allow.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
